-
1
-
-
0023625745
-
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study
-
Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147 (1987) 1561-1564
-
(1987)
Arch Intern Med
, vol.147
, pp. 1561-1564
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
2
-
-
0026543430
-
Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk
-
Stroke Prevention in Atrial Fibrillation Investigators
-
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116 (1992) 1-5
-
(1992)
Ann Intern Med
, vol.116
, pp. 1-5
-
-
-
3
-
-
0028244264
-
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials
-
Atrial Fibrillation Investigators
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-1457
-
-
-
4
-
-
33746833635
-
ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation)
-
Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 48 (2006) 854-906
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 854-906
-
-
Fuster, V.1
Ryden, L.E.2
Cannom, D.S.3
-
5
-
-
0035854054
-
Validation of clinical classification schemes for predicting stroke: results from a national registry of atrial fibrillation
-
Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from a national registry of atrial fibrillation. JAMA 285 (2001) 2864-2870
-
(2001)
JAMA
, vol.285
, pp. 2864-2870
-
-
Gage, B.F.1
Waterman, A.D.2
Shannon, W.3
-
6
-
-
0042422040
-
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study
-
Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 (2003) 1049-1056
-
(2003)
JAMA
, vol.290
, pp. 1049-1056
-
-
Wang, T.J.1
Massaro, J.M.2
Levy, D.3
-
7
-
-
0024543543
-
Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study
-
Petersen P., Boysen G., Godtfredsen J., et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1 (1989) 175-178
-
(1989)
Lancet
, vol.1
, pp. 175-178
-
-
Petersen, P.1
Boysen, G.2
Godtfredsen, J.3
-
8
-
-
0025914693
-
Stroke Prevention in Atrial Fibrillation Study: Final Results
-
Stroke Prevention in Atrial Fibrillation Investigators
-
Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Final Results. Circulation 84 (1991) 527-539
-
(1991)
Circulation
, vol.84
, pp. 527-539
-
-
-
9
-
-
0025241137
-
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
-
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
-
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323 (1990) 1505-1511
-
(1990)
N Engl J Med
, vol.323
, pp. 1505-1511
-
-
-
10
-
-
0025814587
-
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
-
Connolly S., Laupacis A., Gent M., et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18 (1991) 349-355
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 349-355
-
-
Connolly, S.1
Laupacis, A.2
Gent, M.3
-
11
-
-
0026478818
-
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
-
Ezekowitz M., Bridgers S., James K., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327 (1992) 1406-1412
-
(1992)
N Engl J Med
, vol.327
, pp. 1406-1412
-
-
Ezekowitz, M.1
Bridgers, S.2
James, K.3
-
12
-
-
0026048320
-
Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials
-
Albers G.W., Sherman D.G., Gress D.R., et al. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol 30 (1991) 511-518
-
(1991)
Ann Neurol
, vol.30
, pp. 511-518
-
-
Albers, G.W.1
Sherman, D.G.2
Gress, D.R.3
-
13
-
-
36448950800
-
-
Anticoagulant coumadin tablets (warfarin sodium tablets, USP crystalline). In: Physicians Desk Reference. 61st edition, 2007; Thomson PDR at Montvale, NJ; pp 898-903.
-
-
-
-
14
-
-
0029741822
-
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
-
Hylek E., Skates S., Sheehan M., et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335 (1996) 540-546
-
(1996)
N Engl J Med
, vol.335
, pp. 540-546
-
-
Hylek, E.1
Skates, S.2
Sheehan, M.3
-
15
-
-
0042387879
-
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
-
Hylek E.M., Go A.S., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 (2003) 1019-1026
-
(2003)
N Engl J Med
, vol.349
, pp. 1019-1026
-
-
Hylek, E.M.1
Go, A.S.2
Chang, Y.3
-
16
-
-
19644400842
-
Advanced age anticoagulation intensity and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
-
Fang M.C., Chang Y., Hylek E.M., et al. Advanced age anticoagulation intensity and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141 (2004) 745-752
-
(2004)
Ann Intern Med
, vol.141
, pp. 745-752
-
-
Fang, M.C.1
Chang, Y.2
Hylek, E.M.3
-
17
-
-
27444435844
-
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
-
NABOR Steering Committee
-
Waldo A.L., Becker R.C., Tapson V.F., et al., NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 (2005) 1729-1736
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1729-1736
-
-
Waldo, A.L.1
Becker, R.C.2
Tapson, V.F.3
-
18
-
-
33746765044
-
Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study
-
Fang M.C., Go A.S., Hylek E.M., et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 54 (2006) 1231-1236
-
(2006)
J Am Geriatr Soc
, vol.54
, pp. 1231-1236
-
-
Fang, M.C.1
Go, A.S.2
Hylek, E.M.3
-
19
-
-
34547680113
-
Stroke prevention in elderly patients with atrial fibrillation
-
Garcia D., and Hylek E. Stroke prevention in elderly patients with atrial fibrillation. Lancet 370 (2007) 460-461
-
(2007)
Lancet
, vol.370
, pp. 460-461
-
-
Garcia, D.1
Hylek, E.2
-
20
-
-
0033527355
-
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis
-
Hart R., Benavente O., McBridge R., et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131 (1999) 492-501
-
(1999)
Ann Intern Med
, vol.131
, pp. 492-501
-
-
Hart, R.1
Benavente, O.2
McBridge, R.3
-
21
-
-
85025410072
-
A differential effect of aspirin on prevention of stroke in atrial fibrillation
-
The SPAF Investigators
-
The SPAF Investigators. A differential effect of aspirin on prevention of stroke in atrial fibrillation. J Stroke Cerebrovasc Dis 3 (1993) 181-188
-
(1993)
J Stroke Cerebrovasc Dis
, vol.3
, pp. 181-188
-
-
-
22
-
-
0035964019
-
Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation
-
Cleland J.G.F., and Kaye G.C. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation. Br Med J 323 (2001) 233
-
(2001)
Br Med J
, vol.323
, pp. 233
-
-
Cleland, J.G.F.1
Kaye, G.C.2
-
23
-
-
9544248668
-
Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atria fibrillation: Stroke Prevention in Atrial Fibrillation III Randomized clinical trial
-
The SPAF Investigators
-
The SPAF Investigators. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atria fibrillation: Stroke Prevention in Atrial Fibrillation III Randomized clinical trial. Lancet 348 (1996) 633-638
-
(1996)
Lancet
, vol.348
, pp. 633-638
-
-
-
24
-
-
0032557174
-
Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin
-
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
-
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. JAMA 279 (1998) 1273-1277
-
(1998)
JAMA
, vol.279
, pp. 1273-1277
-
-
-
25
-
-
0037145826
-
All anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
-
van Walraven C., Hart R.G., Singer D.E., et al. All anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 288 (2002) 2441-2448
-
(2002)
JAMA
, vol.288
, pp. 2441-2448
-
-
van Walraven, C.1
Hart, R.G.2
Singer, D.E.3
-
26
-
-
0035837496
-
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
-
Klein A.L., Grimm R.A., Murray R.D., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344 (2001) 1420-1441
-
(2001)
N Engl J Med
, vol.344
, pp. 1420-1441
-
-
Klein, A.L.1
Grimm, R.A.2
Murray, R.D.3
-
27
-
-
0034474717
-
Transesophageal echocardiography (TEE) in atrial fibrillation
-
Thamilarasan M., and Klein A.L. Transesophageal echocardiography (TEE) in atrial fibrillation. Cardiol Clin 18 (2000) 819-831
-
(2000)
Cardiol Clin
, vol.18
, pp. 819-831
-
-
Thamilarasan, M.1
Klein, A.L.2
-
28
-
-
0037028022
-
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
-
Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
-
(2002)
N Engl J Med
, vol.347
, pp. 1825-1833
-
-
Wyse, D.G.1
Waldo, A.L.2
DiMarco, J.P.3
-
29
-
-
19444384304
-
The occurrence and characteristics of stroke events in the AFFIRM study
-
Sherman D.G., Kim S.J., Boop B.S., et al. The occurrence and characteristics of stroke events in the AFFIRM study. Arch Intern Med 105 (2005) 1185-1191
-
(2005)
Arch Intern Med
, vol.105
, pp. 1185-1191
-
-
Sherman, D.G.1
Kim, S.J.2
Boop, B.S.3
-
30
-
-
0037028033
-
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
-
van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
-
(2002)
N Engl J Med
, vol.347
, pp. 1834-1840
-
-
van Gelder, I.C.1
Hagens, V.E.2
Bosker, H.A.3
-
31
-
-
27144522548
-
Asymptomatic atrial fibrillation
-
Rho R.W., and Page R.L. Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 48 (2005) 79-87
-
(2005)
Prog Cardiovasc Dis
, vol.48
, pp. 79-87
-
-
Rho, R.W.1
Page, R.L.2
-
32
-
-
0347228969
-
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care
-
Israel C.W., Gronefeld G., Ehrlich J.R., et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 47-52
-
-
Israel, C.W.1
Gronefeld, G.2
Ehrlich, J.R.3
-
33
-
-
34447617533
-
New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device
-
Martinek M., Aichinger J., Nesser H.J., et al. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol 18 (2007) 818-823
-
(2007)
J Cardiovasc Electrophysiol
, vol.18
, pp. 818-823
-
-
Martinek, M.1
Aichinger, J.2
Nesser, H.J.3
-
34
-
-
36448941800
-
Guidelines for anticoagulation of atrial fibrillation: is it time for an update?
-
Raviele A. (Ed), Springer-Verlag Italia, Italy
-
Waldo A.L. Guidelines for anticoagulation of atrial fibrillation: is it time for an update?. In: Raviele A. (Ed). Cardiac arrhythmias 2005 (2006), Springer-Verlag Italia, Italy 169-176
-
(2006)
Cardiac arrhythmias 2005
, pp. 169-176
-
-
Waldo, A.L.1
-
35
-
-
34249814933
-
HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS Task Force on Catheter and Surgical Ablation of Atrial Fibrillation)
-
Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS Task Force on Catheter and Surgical Ablation of Atrial Fibrillation). Heart Rhythm 4 (2007) 816-861
-
(2007)
Heart Rhythm
, vol.4
, pp. 816-861
-
-
Calkins, H.1
Brugada, J.2
Packer, D.L.3
-
36
-
-
34247523351
-
Venice Chart international consensus document on atrial fibrillation ablation
-
Natale A., Raviele A., Arentz T., et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 18 (2007) 560-580
-
(2007)
J Cardiovasc Electrophysiol
, vol.18
, pp. 560-580
-
-
Natale, A.1
Raviele, A.2
Arentz, T.3
-
37
-
-
0038300657
-
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Outcomes from a controlled, nonrandomized long term study
-
Pappone C., Rosario S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Outcomes from a controlled, nonrandomized long term study. J Am Coll Cardiol 42 (2003) 185-197
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 185-197
-
-
Pappone, C.1
Rosario, S.2
Augello, G.3
-
38
-
-
33747622292
-
Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation
-
Oral H., Chugh A., Ozaydin M., et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114 (2006) 759-765
-
(2006)
Circulation
, vol.114
, pp. 759-765
-
-
Oral, H.1
Chugh, A.2
Ozaydin, M.3
|